Nombre del producto:(S)-4-(tert-Butoxycarbonyl)-1,4-oxazepane-2-carboxylic acid

IUPAC Name:(2S)-4-[(tert-butoxy)carbonyl]-1,4-oxazepane-2-carboxylic acid

CAS:1273567-44-4
Fórmula molecular:C11H19NO5
Pureza:95%
Número de catálogo:CM284795
Peso molecular:245.28

Unidad de embalaje Stock disponible Precio($) Cantidad
CM284795-1g in stock ȤȤƚ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1273567-44-4
Fórmula molecular:C11H19NO5
Punto de fusión:-
Código de sonrisas:O=C([C@H]1OCCCN(C(OC(C)(C)C)=O)C1)O
Densidad:
Número de catálogo:CM284795
Peso molecular:245.28
Punto de ebullición:384.0±42.0°C at 760 mmHg
Nº Mdl:MFCD19442252
Almacenamiento:Store at 2-8°C.

Column Infos

Brensocatib
May 28 2024, Insmed announced positive topline results from landmark ASPEN study of Brensocatib in patients with bronchiectasis.
Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1) being developed for the treatment of patients with bronchiectasis, CRSsNP, and other neutrophil-mediated diseases. DPP1 is an enzyme responsible for activating neutrophil serine proteases (NSPs), such as neutrophil elastase, in neutrophils when they are formed in the bone marrow. Brensocatib is an investigational drug product that has not been approved for any indication in any jurisdiction.

Related Products